PANTHERA BIOPHARMA, LLC

Basic Information

PANTHERA BIOPHARMA, LLC
99-193 AIEA HEIGHTS DR, STE 136
AIEA, HI, 96701

Company Profile

n/a

Additional Details

Field Value
DUNS: 620852769
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Discovery of Broad Spectrum Dengue Virus Proteinase Inhibitors

    Amount: $599,957.00

    DESCRIPTION (provided by applicant): Over half of the world population is at risk for infection by dengue virus, a mosquito borne member of the Flavivirus family that consists of four distinct serotyp ...

    SBIR Phase I 2008 Department of Health and Human Services
  2. Inhibitors of Anthrax Lethal Factor Metalloproteinase

    Amount: $899,971.00

    DESCRIPTION (provided by applicant): Anthrax Lethal Factor (LF) is a metalloproteinase introduced into the cells of mammalian hosts during infection by the bacterium Bacillus anthracis. LF disrupts in ...

    SBIR Phase II 2007 Department of Health and Human Services
  3. Development of a Recombinant Subunit Ebola Vaccine

    Amount: $479,882.00

    DESCRIPTION (provided by applicant): Ebola and Marburg viruses, the only members of the family Filoviridae, cause hemorrhagic fevers which are lethal in up to 90% of human cases. No vaccine or antivir ...

    SBIR Phase I 2007 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government